Zdrowie i gospodarka · 07/06/2007
FDA Clears Cefotetan Disodium for New Drug Applications
The FDA has determined that Cefotan, a cefotetan disodium injection, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →